$13.5 Billion is the total value of Paulson & Co.'s 97 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 129.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SHPG | Buy | SHIRE PLCsponsored adr | $1,215,513,000 | -13.4% | 7,071,050 | +3.3% | 8.99% | +7.1% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $1,102,424,000 | -17.7% | 20,602,200 | +0.9% | 8.15% | +1.8% |
| MYL | Buy | MYLAN N V | $1,081,617,000 | -12.2% | 23,335,861 | +2.4% | 8.00% | +8.6% |
| MNKKQ | Buy | MALLINCKRODT PUB LTD CO | $548,418,000 | -14.8% | 8,949,380 | +3.8% | 4.06% | +5.4% |
| VRX | Buy | VALEANT PHARMACEUTICALS INTL | $349,390,000 | -74.1% | 13,284,800 | +0.1% | 2.58% | -68.0% |
| GRFS | Buy | GRIFOLS S Asp adr rep b nvt | $271,247,000 | -32.5% | 17,533,764 | +41.4% | 2.01% | -16.5% |
| ENDP | Buy | ENDO INTL PLC | $267,918,000 | +32.5% | 9,517,500 | +188.2% | 1.98% | +64.0% |
| AKRXQ | Buy | AKORN INC | $219,267,000 | +104.1% | 9,318,600 | +223.7% | 1.62% | +152.5% |
| BEAV | New | B/E AEROSPACE INC | $138,360,000 | – | 3,000,000 | +100.0% | 1.02% | – |
| ATVI | New | ACTIVISION BLIZZARD INC | $106,258,000 | – | 3,140,000 | +100.0% | 0.79% | – |
| CVC | Buy | CABLEVISION SYS CORPcl a ny cablvs | $105,650,000 | +7.1% | 3,201,500 | +3.5% | 0.78% | +32.4% |
| ACAS | New | AMERICAN CAP LTD | $60,577,000 | – | 3,974,900 | +100.0% | 0.45% | – |
| AGN | New | ALLERGAN PLCcall | $57,546,000 | – | 214,700 | +100.0% | 0.42% | – |
| ODP | New | OFFICE DEPOT INC | $55,448,000 | – | 7,809,600 | +100.0% | 0.41% | – |
| RDN | Buy | RADIAN GROUP INC | $45,497,000 | +191.0% | 3,669,124 | +214.2% | 0.34% | +261.3% |
| PFE | Buy | PFIZER INC | $40,847,000 | +100.0% | 1,378,100 | +117.8% | 0.30% | +147.5% |
| BIIB | Buy | BIOGEN INC | $30,822,000 | +177.9% | 118,400 | +227.1% | 0.23% | +245.5% |
| SGYPQ | Buy | SYNERGY PHARMACEUTICALS DEL | $30,608,000 | -40.0% | 11,090,000 | +23.2% | 0.23% | -25.9% |
| MYL | New | MYLAN N Vcall | $28,329,000 | – | 611,200 | +100.0% | 0.21% | – |
| PFE | New | PFIZER INCcall | $23,712,000 | – | 800,000 | +100.0% | 0.18% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $21,885,000 | – | 157,200 | +100.0% | 0.16% | – |
| ETSY | Buy | ETSY INC | $12,788,000 | +254.2% | 1,469,910 | +236.4% | 0.10% | +331.8% |
| DWRE | Buy | DEMANDWARE INC | $10,812,000 | +49.5% | 276,527 | +106.4% | 0.08% | +86.0% |
| LBTYA | Buy | LIBERTY GLOBAL | $10,780,000 | +41.4% | 280,000 | +55.6% | 0.08% | +73.9% |
| SHPG | New | SHIRE PLCcall | $9,970,000 | – | 58,000 | +100.0% | 0.07% | – |
| MCK | Buy | MCKESSON CORP | $9,828,000 | +515.0% | 62,500 | +671.6% | 0.07% | +630.0% |
| EXPE | New | EXPEDIA INC DEL | $9,467,000 | – | 87,800 | +100.0% | 0.07% | – |
| OIBRC | New | OI S.A.sponsored adr new | $7,564,000 | – | 5,327,034 | +100.0% | 0.06% | – |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $6,735,000 | – | 54,000 | +100.0% | 0.05% | – |
| LOXO | Buy | LOXO ONCOLOGY INC | $6,161,000 | +163.5% | 225,341 | +174.2% | 0.05% | +228.6% |
| BXLT | New | BAXALTA INC | $5,539,000 | – | 137,100 | +100.0% | 0.04% | – |
| FB | New | FACEBOOK INCcl a | $5,020,000 | – | 44,000 | +100.0% | 0.04% | – |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $4,889,000 | -16.3% | 61,500 | +32.5% | 0.04% | +2.9% |
| TNDM | New | TANDEM DIABETES CARE INCput | $4,703,000 | – | 540,000 | +100.0% | 0.04% | – |
| VRX | New | VALEANT PHARMACEUTICALS INTLput | $4,466,000 | – | 169,800 | +100.0% | 0.03% | – |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $3,842,000 | +18.8% | 199,700 | +49.3% | 0.03% | +47.4% |
| ENDP | New | ENDO INTL PLCcall | $3,375,000 | – | 119,900 | +100.0% | 0.02% | – |
| DXCM | New | DEXCOM INC | $2,805,000 | – | 41,300 | +100.0% | 0.02% | – |
| JAH | New | JARDEN CORP | $2,753,000 | – | 46,700 | +100.0% | 0.02% | – |
| INSM | Buy | INSMED INC | $2,600,000 | -13.3% | 205,200 | +24.2% | 0.02% | +5.6% |
| ARG | New | AIRGAS INC | $2,110,000 | – | 14,900 | +100.0% | 0.02% | – |
| RAD | New | RITE AID CORP | $2,148,000 | – | 263,500 | +100.0% | 0.02% | – |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $2,065,000 | -42.7% | 70,300 | +52.8% | 0.02% | -31.8% |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $2,079,000 | +29.8% | 999,700 | +89.1% | 0.02% | +50.0% |
| VRX | New | VALEANT PHARMACEUTICALS INTLcall | $1,923,000 | – | 73,100 | +100.0% | 0.01% | – |
| ESPR | Buy | ESPERION THERAPEUTICS INC NE | $1,725,000 | +244.3% | 102,000 | +353.3% | 0.01% | +333.3% |
| ITC | New | ITC HLDGS CORP | $1,638,000 | – | 37,600 | +100.0% | 0.01% | – |
| SNDK | New | SANDISK CORP | $1,582,000 | – | 20,800 | +100.0% | 0.01% | – |
| BSX | New | BOSTON SCIENTIFIC CORP | $1,392,000 | – | 74,000 | +100.0% | 0.01% | – |
| IM | New | INGRAM MICRO INCcl a | $1,045,000 | – | 29,100 | +100.0% | 0.01% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS | $745,000 | – | 263,100 | +100.0% | 0.01% | – |
| OSG | New | OVERSEAS SHIPHOLDING GROUP I | $509,000 | – | 270,839 | +100.0% | 0.00% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $268,000 | – | 70,800 | +100.0% | 0.00% | – |
| ARDMQ | New | ARADIGM CORP | $87,000 | – | 19,662 | +100.0% | 0.00% | – |
| CYH | New | COMMUNITY HEALTH SYS INC NEWput | $53,000 | – | 350,000 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
About Paulson & Co.
Paulson & Co. is a New York-based investment management firm founded by John Paulson in 1994. The firm is known for its expertise in event-driven investing, which involves taking advantage of market inefficiencies created by corporate events such as mergers, acquisitions, bankruptcies, and spin-offs. Paulson & Co. manages approximately $9 billion in assets and has a team of over 100 professionals.
John Paulson, the founder and CEO of Paulson & Co., is a renowned hedge fund manager who made a fortune by betting against the subprime mortgage market in 2007. He is considered one of the most successful investors of his generation, with a net worth of over $4 billion. Paulson is actively involved in the management of the firm and oversees the investment strategy.
Paulson & Co. has a strong track record of generating high returns for its investors. The firm's flagship fund, the Paulson Advantage Fund, has delivered an average annual return of 12.5% since its inception in 1994. The fund has also outperformed the S&P 500 index in 16 out of the past 22 years.
In recent years, Paulson & Co. has faced some challenges, including a decline in assets under management and a series of high-profile losses. However, the firm has remained committed to its investment philosophy and has continued to generate strong returns for its investors. With a talented team of professionals and a proven track record of success, Paulson & Co. is well-positioned to continue delivering value to its clients in the years ahead.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NOVAGOLD RESOURCES INC | 42 | Q3 2023 | 12.0% |
| INTERNATIONAL TOWER HILL MINE | 42 | Q3 2023 | 3.4% |
| IAMGOLD CORP | 42 | Q3 2023 | 0.5% |
| ANGLOGOLD ASHANTI-SPON ADR | 41 | Q2 2023 | 7.9% |
| AGNICO EAGLE MINES LTD | 34 | Q3 2023 | 3.8% |
| SPDR GOLD TRUST | 33 | Q1 2022 | 13.3% |
| TRILOGY METALS INC NEW | 29 | Q3 2023 | 0.9% |
| ENDO INTL PLC | 28 | Q2 2022 | 3.4% |
| CAESARS ENTMT CORP | 27 | Q4 2019 | 4.6% |
| TIM PARTICIPACOES SA-ADR | 26 | Q3 2020 | 2.4% |
View Paulson & Co.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Thryv Holdings, Inc. | February 14, 2023 | 2,000,000 | 5.8% |
| Endo International plc | February 14, 2022 | 17,327,012 | 7.4% |
| BrightSphere Investment Group Inc. | December 22, 2021 | 8,950,121 | 19.8% |
| PERPETUA RESOURCES CORP. | August 27, 2021 | 20,929,280 | 33.3% |
| Bausch Health Companies Inc. | May 15, 2020 | 25,839,035 | 7.3% |
| OVERSEAS SHIPHOLDING GROUP INC | April 13, 2020 | 6,300,000 | 7.3% |
| SYNTHESIS ENERGY SYSTEMS INC | February 14, 2020 | 165,648 | 10.5% |
| Callon Petroleum Co | November 18, 2019 | 10,338,663 | 4.5% |
| International Seaways, Inc. | July 03, 2019 | 1,459,119 | 5.0% |
| AKORN INCSold out | February 14, 2018 | 0 | 0.0% |
View Paulson & Co.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-01-22 |
| SC 13D/A | 2024-01-22 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
View Paulson & Co.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.